Gut Journal

Gut is a medical journal that focuses on gastroenterology and hepatology, and it is reviewed monthly by experts in the field. This journal is affiliated with the British Society of Gastroenterology and is published by the BMJ Group. Since 2013, Emad El-Omar has been serving as the editor-in-chief.

International, Trade/B2B

English

Journal

Outlet metrics

Domain Authority

Ranking

Global

N/A

Country

N/A

Articles

Metabolic dysfunction-associated steatotic liver disease in children

3 weeks ago | gut.bmj.com | Nidhi Goyal |Stavra A. Xanthakos |Jeffrey B. Schwimmer |Cincinnati Children's

Recent advances in clinical practice Metabolic dysfunction-associated steatotic liver disease in children Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Perplexing case of abdominal pain with eosinophilia and fasciitis

1 month ago | gut.bmj.com | Robert O'Neill |Logan Gardner |Anthony D. Kelleher |Roger Pamphlett

Cookies and privacyWe and our 138 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting "I Accept" enables tracking technologies to support the purposes shown under "we and our partners process data to provide," whereas selecting "Reject All" or withdrawing your consent will disable them. If trackers are disabled, some content and ads you see may not be as relevant to you.
Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B

1 month ago | gut.bmj.com | David Pan |Cameron M. Soulette |Abhishek Aggarwal |Dong Cheol Han

Effects of tenofovir disoproxil fumarate on intrahepatic viral burden and liver immune microenvironment in patients with chronic hepatitis B Free Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists

2 months ago | gut.bmj.com | Christopher Byrne |Giovanni Targher |Alessandro Mantovani |Herbert Tilg

FootnotesContributors GT, AM, CDB and HT contributed equally to the manuscript. GT is the guarantor for the overall content of the manuscript. Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Competing interests HT is an associate editor of the journal, and GT is an editorial board member of the journal. The authors do not have other potential conflicts of interest to disclose.
EMERALD in the making? A promising blood-based microRNA panel to detect oesophageal adenocarcinoma and Barrett’s oesophagus

2 months ago | gut.bmj.com | Prasad G. Iyer

BARRETT'S OESOPHAGUS OESOPHAGEAL CANCER Screening for oesophageal adenocarcinoma (OAC), a lethal cancer, when diagnosed after the onset of symptoms, and its sole known precursor, Barrett’s oesophagus (BO), though suggested by guidelines, remains underused.1 Support for screening is underpinned by level 1 evidence demonstrating the ability of endoscopic therapy of BO dysplasia to prevent progression to OAC and the excellent survival of patients with T1 OAC treated with endoscopic therapy.2...
Reassessing gastroscopy practices: the need for improved methodology and interpretation

Jan 17, 2025 | gut.bmj.com | Jia Xu |Xiaowei Tang

Cookies and privacyWe and our 128 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting "I Accept" enables tracking technologies to support the purposes shown under "we and our partners process data to provide," whereas selecting "Reject All" or withdrawing your consent will disable them. If trackers are disabled, some content and ads you see may not be as relevant to you.
GI highlights from the literature

Jan 17, 2025 | gut.bmj.com | Philip Smith

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. GASTROINTESINAL ENDOSCOPYBasic scienceKiourtis C, Terradas-Terradas M, Gee L, et al. Hepatocellular senescence induces multi-organ senescence and dysfunction via TGFβ.
Accuracy of histopathology evaluation in diminutive colonic polyps diagnosed as neoplastic by computer-aided characterisation

Dec 31, 2024 | gut.bmj.com | von Renteln

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
GI highlights from the literature

Dec 10, 2024 | gut.bmj.com | Philip Smith

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways. GASTROINTESTINAL FUNCTIONBasic scienceCheng J, Venkatesh S, Ke K, et al. A human gut Faecalibacterium prausnitzii fatty acid amide hydrolase. Science 2024;3866720:eado6828.
FTO/m6A/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment?

Dec 10, 2024 | gut.bmj.com | Bernd Heinrich |Francisco Javier Cubero

Cookies and privacyWe and our 123 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting "I Accept" enables tracking technologies to support the purposes shown under "we and our partners process data to provide," whereas selecting "Reject All" or withdrawing your consent will disable them. If trackers are disabled, some content and ads you see may not be as relevant to you.